133 related articles for article (PubMed ID: 10096501)
1. In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA).
Dittmann H; Coenen HH; Zölzer F; Dutschka K; Brandau W; Streffer C
Nucl Med Biol; 1999 Jan; 26(1):51-6. PubMed ID: 10096501
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
3. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
4. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
[TBL] [Abstract][Full Text] [Related]
5. Melanin-targeted preclinical PET imaging of melanoma metastasis.
Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
[TBL] [Abstract][Full Text] [Related]
6. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
[TBL] [Abstract][Full Text] [Related]
8. Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.
Labarre P; Papon J; Moreau MF; Moins N; Bayle M; Veyre A; Madelmont JC
Melanoma Res; 2002 Apr; 12(2):115-21. PubMed ID: 11930107
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
10. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated methylene blue--a promising agent for melanoma scintigraphy: labelling, stability and in vitro uptake by melanoma cells.
Sobal G; Rodrigues M; Sinzinger H
Anticancer Res; 2008; 28(6A):3691-6. PubMed ID: 19189650
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
14. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
[TBL] [Abstract][Full Text] [Related]
15. Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.
Chehade F; De Labriolle-Vaylet C; Michelot J; Moins N; Moreau MF; Hindié E; Papon J; Escaig F; Galle P; Veyre A
Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):529-34. PubMed ID: 11441960
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
Chen CC; Chen YY; Lo YH; Lin MH; Chang CH; Chen CL; Wang HE; Wu CY
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916962
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
18. Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.
Mansard S; Papon J; Moreau MF; Miot-Noirault E; Labarre P; Bayle M; Veyre A; Madelmont JC; Moins N
Nucl Med Biol; 2005 Jul; 32(5):451-8. PubMed ID: 15982575
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells.
John CS; Vilner BJ; Bowen WD
J Med Chem; 1994 Jun; 37(12):1737-9. PubMed ID: 8021913
[No Abstract] [Full Text] [Related]
20. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
